Organogenesis Holdings (ORGO) Change in Inventory (2018 - 2026)
Organogenesis Holdings (ORGO) recorded quarterly Change in Inventory of $8.7 million in Q1 2026, up 194.83% quarter-over-quarter from $3.0 million in Q4 2025, and little changed on a YoY basis from $8.7 million in Q1 2025.
Organogenesis Holdings (ORGO) Change in Inventory (2018 - 2026) Analysis & Trends
Organogenesis Holdings' Change in Inventory history runs 9 years deep, the most recent figure standing at $8.7 million for Q1 2026.
- In Q1 2026, Change in Inventory changed 0.02% year-over-year to $8.7 million; the TTM figure through Mar 2026 stood at $17.9 million (up 74.49% YoY), while the FY2025 annual figure was $17.9 million, up 188.77% from the prior year.
- Change in Inventory was $8.7 million for Q1 2026 at Organogenesis Holdings, up from $3.0 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $8.7 million in Q1 2025 to a low of -$2.7 million in Q2 2024.
- Historically, Change in Inventory has averaged $3.0 million across 5 years, with a median of $3.0 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Change in Inventory surged 2803.75% in 2023, then tumbled 241.39% in 2024.
- A 5-year view of Change in Inventory shows it stood at $2.1 million in 2022, then sank by 66.82% to $706000.0 in 2023, then tumbled by 35.55% to $455000.0 in 2024, then surged by 550.77% to $3.0 million in 2025, then soared by 194.83% to $8.7 million in 2026.
- The last three Change in Inventory figures came in at $8.7 million (Q1 2026), $3.0 million (Q4 2025), and -$938000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -93.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 114.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 40.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -4.30 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 6.43 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -2.11 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 20.30 Mn |
| 10 | Organogenesis Holdings | 304.80 Mn | 212.70 Mn | 11.46 Mn | 8.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.73 Mn |
| Mar 31, 2026 | 8.73 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Sep 30, 2025 | -938,000.00 |
| Sep 30, 2025 | -938,000.00 |
| Jun 30, 2025 | 7.16 Mn |
| Jun 30, 2025 | 7.16 Mn |
| Mar 31, 2025 | 8.73 Mn |
| Mar 31, 2025 | 8.73 Mn |
| Dec 31, 2024 | 455,000.00 |
| Dec 31, 2024 | 455,000.00 |
| Sep 30, 2024 | 3.74 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Jun 30, 2024 | -2.66 Mn |
| Jun 30, 2024 | -2.66 Mn |
| Mar 31, 2024 | 4.67 Mn |
| Mar 31, 2024 | 4.67 Mn |
| Dec 31, 2023 | 706,000.00 |
| Dec 31, 2023 | 706,000.00 |